This website uses cookies
TROG Cancer Research uses cookies to personalise content and ads, to provide specialised marketing features and analyse our traffic. We also share information about your use of our site with our marketing agency who may combine this data with other information that you have provided, or that has been collected from your use of our services.
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292